Document is current
Any future updates will be listed below
-
Authors
Hack, Laura M.
Jubeir, Jenna https://orcid.org/0009-0009-2338-9593
Hilton, Rachel https://orcid.org/0000-0002-7943-2206
Tozzi, Leonardo https://orcid.org/0000-0002-9429-6476
Boyar, Leyla
Zhang, Xue
Lyons, Timothy
Jo, Booil
O’Hara, Ruth
Schatzberg, Alan F. https://orcid.org/0000-0001-9421-8278
Williams, Leanne M. https://orcid.org/0000-0001-9987-7360
-
Funding
Funding for this research was provided by:
The Stanford Innovative Medicines Accelerator (IMA) seeks to accelerate the translation of Stanford research discoveries into new medicines while expanding our knowledge of human biology.
U.S. Department of Health & Human Services | National Institutes of Health (U01MH136062, U01MH136062, U01MH136062, U01MH136062, U01MH136062, 1UM1TR004921-01)
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (U01MH136062)
- License Information
-
More Information
Article History
Received: 4 January 2025
Accepted: 26 August 2025
First Online: 13 October 2025
Competing interests
: L.M.W. declares US patent applications 10/034,645 and 15/820,338: Systems and methods for detecting complex networks in MRI image data. A.F.S. has consulted for Compass, Axsome, ANeuroTech, NeuraWell, Signant, Otsuka, Sage, Douglas, Alto, Magnus, Skyland Trail and Parexel. He has equity in Corcept, Alto Neuroscience, Magnus, Delport, Insight Analytics, Madrigal, Seattle Genetics, Titan and Xhale. L.T. is employed by Ceribell Inc. The other authors declare no competing interests.
